Literature DB >> 16170665

Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment.

Ana Maria Mendes Pereira1, Mary Strasberg-Rieber, Manuel Rieber.   

Abstract

Matrix metalloproteinases, like MMP-2 and MMP-9 gelatinases, show multiple functions as extracellular/cell-surface enzymes, and are broadly recognised for their matrix-degrading ability and involvement in cell motility. Given that adherent cells have reduced attachment during migration and also detach from their substratum during apoptosis, we now investigated whether extracellular matrix-bound gelatinases and intracellular MMP-2 and MMP-9 are modified with progression of death-inducing stimuli. This report shows that melanoma cells undergoing death in response to 2-acetyl furanonaphtoquinone (FNQ) as evidenced by greater Annexin V binding, increased cytosolic expression of pro-MMP-2 and intracellular activation of particulate MMP-9. These changes were associated with early activation of a substrate-attached 40 kDa gelatinase reciprocal with changes in extracellular matrix-bound activated MMP-2. A subsequent activation of secreted MMP-9 and induction of apoptosis-associated fragmentation of poly ADP-Ribose polymerase (PARP) correlated with cell detachment. Our data suggests that intracellularly activated gelatinases may cleave survival-associated substrates other than gelatin that share the Gly-Leu/Iso-Pro like collagen-binding acetylcholinesterase, thereby linking them to apoptosis associated with cell detachment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170665     DOI: 10.1007/s10585-005-8672-8

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  46 in total

1.  Detection of genomic DNA fragmentation during apoptosis (DNA ladder) and the simultaneous isolation of RNA from low cell numbers.

Authors:  P T Daniel; I Sturm; S Ritschel; K Friedrich; B Dörken; P Bendzko; T Hillebrand
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365

2.  Mitochondrial damage by a new antitumour agent furanonaphthoquinone derivative in human cervical cancer HeLa cells.

Authors:  J Pan; K I Hirai; E Simamura; J Koyama; H Shimada; S Kuwabara
Journal:  J Electron Microsc (Tokyo)       Date:  1997

3.  Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells.

Authors:  K I Hirai; J Koyama; J Pan; E Simamura; H Shimada; T Yamori; S Sato; K Tagahara; T Tsuruo
Journal:  Cancer Detect Prev       Date:  1999

4.  Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms.

Authors:  G V Glinsky; V V Glinsky; A B Ivanova; C J Hueser
Journal:  Cancer Lett       Date:  1997-05-19       Impact factor: 8.679

Review 5.  Matrix metalloproteinases in human melanoma.

Authors:  U B Hofmann; J R Westphal; G N Van Muijen; D J Ruiter
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

6.  Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles.

Authors:  M Nguyen; J Arkell; C J Jackson
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

8.  Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.

Authors:  N Boudreau; C J Sympson; Z Werb; M J Bissell
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

9.  The cytoskeleton of digitonin-treated rat hepatocytes.

Authors:  G Fiskum; S W Craig; G L Decker; A L Lehninger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene.

Authors:  C M Alexander; E W Howard; M J Bissell; Z Werb
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

View more
  16 in total

1.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

2.  Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA).

Authors:  Martina Ramella; Francesca Boccafoschi; Kevin Bellofatto; Antonia Follenzi; Luca Fusaro; Renzo Boldorini; Francesco Casella; Carla Porta; Piergiorgio Settembrini; Mario Cannas
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells.

Authors:  Wen Huang; Geun Bae Rha; Lei Chen; Melissa J Seelbach; Bei Zhang; Ibolya E András; Dennis Bruemmer; Bernhard Hennig; Michal Toborek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-05       Impact factor: 4.733

4.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

5.  Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.

Authors:  Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-10       Impact factor: 5.650

6.  Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Cell Int       Date:  2010-03-24       Impact factor: 5.722

7.  Structure-Activity Relationship of Chlorotoxin-Like Peptides.

Authors:  Syed Abid Ali; Mehtab Alam; Atiya Abbasi; Eivind A B Undheim; Bryan Grieg Fry; Hubert Kalbacher; Wolfgang Voelter
Journal:  Toxins (Basel)       Date:  2016-02-02       Impact factor: 4.546

Review 8.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Rugmani Padmanabhan Iyer; Michael E Hall; Merry L Lindsey
Journal:  Physiology (Bethesda)       Date:  2013-11

9.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

Review 10.  Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments.

Authors:  I H Bellayr; X Mu; Y Li
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.